Cardiology

Indications

cardiologie_img

Clinical study with our solution

                                     Clinical study with our solution

Logo_TheAllanLab
-39%-14%
      PAIN       ANXIOLYTIC

Virtual reality – a new addition to the anxiolytic array for cardiac device implantation, The Allan Lab Immersive Research, 2022

C. Brown, et al.

Results: Lower reported pain (visual analogue scale; 1.9 vs. 3.1); Post-procedure anxiety was similar in both groups (State-Trait Anxiety Index; 80.4 vs. 81.9); Fewer patients required the anxiolytic midazolam (11% vs. 25%); Three patients in the VR group (33%) fell asleep during the procedure, compared to only one in the standard care group (13%).

References